Large-scale clinical trial finds cannabidiol can dramatically reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox–Gastaut syndrome.
Novel cannabinoids could provide new therapy options for patients with drug-resistant epilepsy.
Kalytera bolsters advisory board with 3 pain research experts to aid their development of a safe drug for intractable pain that doesn't get you high.
The researchers behind the drug formulation believe their technology is a game changer for the medical community and solves many patient problems.
While great strides have been made to reduce children's exposure to second-hand cigarette smoke, those efforts may be undermined by increasing use of cannabis among parents with children living at home.
80% of oncologists discuss medical marijuana with patients and nearly half recommend its clinical use but, less than 30% consider themselves knowledgeable enough to make such recommendations,
Cannabinoids including THC found to be effective antibiotics for C. diff, VRE, and a variety of additional pathogens linked to diarrhea and colitis.